|
TRI-611 Clinical Trials
1 actively recruiting trial across 1 location
No change since June 2026
Pipeline
Phase 1/2: 1
Top Sponsors
- TRIANA Biomedicines, Inc.1
Indications
- ALK-positive NSCLC1
- ALK-Positive Lung Cancer1
- ALK Positive Non-small Cell Lung Cancer1
- Lung Cancer1
- Cancer1
San Francisco, California1 trial
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.